Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
2016 · Kidney International · 468 citations
https://doi.org/10.1016/j.kint.2015.10.002
A
Amy Barton Pai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
2.4K
Citations
23
h-index
38
i10-index
Amy Barton Pai is an academic researcher from Vifor Pharma (Switzerland). The author has contributed to research in topics: Iron Metabolism and Disorders & Dialysis and Renal Disease Management & Erythropoietin and Anemia Treatment. The author has an h-index of 23, co-authored 64 publications.
ORCID: 0000-0002-7131-5267Papers by this author
worksEarly Rehospitalization After Kidney Transplantation: Assessing Preventability and Prognosis
2013 · American Journal of Transplantation · 93 citations
https://doi.org/10.1111/ajt.12513
Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival
2010 · BMC Nephrology · 44 citations
https://doi.org/10.1186/1471-2369-11-16
Iron-based phosphate binders – a new element in management of hyperphosphatemia
2015 · Expert Opinion on Drug Metabolism & Toxicology · 14 citations
https://doi.org/10.1517/17425255.2016.1110573
Assessment of literacy and numeracy skills related to medication labels in patients on chronic in-center hemodialysis
2020 · Journal of the American Pharmacists Association · 12 citations
https://doi.org/10.1016/j.japh.2020.07.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat